Arrowstreet Capital Limited Partnership Has $7.27 Million Holdings in Molina Healthcare, Inc. (NYSE:MOH)

Arrowstreet Capital Limited Partnership lowered its stake in shares of Molina Healthcare, Inc. (NYSE:MOH) by 91.6% in the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 24,990 shares of the company’s stock after selling 271,321 shares during the period. Arrowstreet Capital Limited Partnership’s holdings in Molina Healthcare were worth $7,273,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Versant Capital Management Inc boosted its position in shares of Molina Healthcare by 83.1% during the fourth quarter. Versant Capital Management Inc now owns 163 shares of the company’s stock valued at $47,000 after buying an additional 74 shares during the last quarter. Wingate Wealth Advisors Inc. bought a new stake in shares of Molina Healthcare in the 4th quarter worth $52,000. EverSource Wealth Advisors LLC raised its holdings in shares of Molina Healthcare by 81.5% in the fourth quarter. EverSource Wealth Advisors LLC now owns 196 shares of the company’s stock valued at $57,000 after purchasing an additional 88 shares during the last quarter. Harvest Fund Management Co. Ltd lifted its position in shares of Molina Healthcare by 895.0% during the fourth quarter. Harvest Fund Management Co. Ltd now owns 199 shares of the company’s stock valued at $58,000 after purchasing an additional 179 shares in the last quarter. Finally, Whittier Trust Co. of Nevada Inc. boosted its holdings in Molina Healthcare by 337.0% during the fourth quarter. Whittier Trust Co. of Nevada Inc. now owns 201 shares of the company’s stock worth $58,000 after purchasing an additional 155 shares during the last quarter. 98.50% of the stock is owned by institutional investors.

Molina Healthcare Price Performance

Shares of NYSE MOH opened at $347.26 on Monday. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.62 and a current ratio of 1.62. Molina Healthcare, Inc. has a fifty-two week low of $262.32 and a fifty-two week high of $383.58. The stock has a market cap of $18.99 billion, a PE ratio of 17.00, a price-to-earnings-growth ratio of 1.06 and a beta of 0.70. The stock has a fifty day moving average of $306.76 and a 200-day moving average of $308.09.

Molina Healthcare (NYSE:MOH) last announced its quarterly earnings results on Wednesday, February 5th. The company reported $5.05 earnings per share for the quarter, missing the consensus estimate of $5.74 by ($0.69). Molina Healthcare had a net margin of 2.90% and a return on equity of 28.13%. Equities research analysts anticipate that Molina Healthcare, Inc. will post 24.4 earnings per share for the current year.

Insiders Place Their Bets

In other news, Director Steven J. Orlando sold 1,000 shares of the company’s stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $301.33, for a total value of $301,330.00. Following the transaction, the director now owns 17,375 shares of the company’s stock, valued at approximately $5,235,608.75. This represents a 5.44 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Corporate insiders own 1.10% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have commented on MOH shares. Barclays dropped their target price on shares of Molina Healthcare from $372.00 to $339.00 and set an “equal weight” rating on the stock in a research report on Friday, February 7th. Mizuho cut their price objective on Molina Healthcare from $382.00 to $376.00 and set an “outperform” rating on the stock in a research report on Monday, March 3rd. JPMorgan Chase & Co. reaffirmed a “neutral” rating and set a $350.00 target price (down from $378.00) on shares of Molina Healthcare in a research report on Tuesday, December 17th. StockNews.com downgraded shares of Molina Healthcare from a “buy” rating to a “hold” rating in a report on Thursday. Finally, Truist Financial decreased their price objective on shares of Molina Healthcare from $370.00 to $340.00 and set a “buy” rating for the company in a report on Wednesday, February 19th. Seven analysts have rated the stock with a hold rating, six have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $348.75.

Molina Healthcare Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.